Credit Suisse Downgrades Edwards Lifesciences to Neutral

Symbols: EW
Share

Credit Suisse has downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Neutral and has raised the price target from $81 to $90.


 
 
< Previous
Gilford Securities Downgrades Eastman Chemical to Hold
Next >
Global Equities Research Downgrades Salesforce.com to Underweight
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust